Michael Shen

Michael Shen has advised high-growth emerging life sciences & technology companies (including Web 3.0 companies) and companies in traditional sectors as well as venture capital, private equity and other firms that invest in those companies on China/US-related corporate and securities transactions, including company formations, spin-offs, venture capital financing, private equity investments, mergers and acquisitions, joint ventures and other strategic transactions, employee equity incentives, corporate governance matters and other general corporate matters.

Michael has also represented clients in connection with complex cross-border commercial transactions involving unique structures and contractual arrangements designed to comply with legal requirements in multiple jurisdictions, including licensing, manufacturing and distribution arrangements in the life sciences, high-tech and other traditional industries in China.